|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Dihydropyrimidine Dehydrogenase Genotype, Varies
Test CodeCPT Codes
81232<br>Restricted Client Code
Physician Attestation of Informed Consent
Preferred Specimen
3 mL whole blood collected in an EDTA (lavender-top) tube, or
3 mL cord blood collected in an EDTA (lavender-top) tube, or
1 swab - saliva collected in a Saliva Collection Kit (T786), or
100 mcl extracted DNA collected in a 2 mL screw-cap Micro Tube with skirted conical base, or 1 mL Matrix tube
Patient Preparation
A previous hematopoietic stem cell transplant from an allogenic donor will interfere with testing. For instructions for testing patients who have a hematopoietic stem cell transplant, call 800-533-1710.
For Saliva:
Patient should not eat, drink, smoke, or chew gum 30 minutes prior to collection.
Minimum Volume
Instructions
Whole Blood, Cord Blood
1. Invert several times to mix blood.
2. Send whole/cord blood specimen in original tube. Do not aliquot.
Saliva:
Collect and send specimen per kit instructions.
Extracted DNA:
1. The preferred volume is at least 100 mcL at a concentration of 75 ng/mcL.
2. Include concentration and volume on tube.
Note:
1. New York Clients-Informed consent is required. Document on the request form or electronic order that a copy is on file. The following documents are available:
-Informed Consent for Genetic Testing (T576)
-Informed Consent for Genetic Testing (Spanish) (T826)
2. If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen.
Transport Temperature
Specimen Stability
Whole blood and cord blood
Room temperature: 4 days
Refrigerated: 4 days
Frozen: 4 days
Saliva
Room temperature: 30 days
Refrigerated: 30 days
Frozen: Unacceptable
Extracted DNA
Room temperature: Acceptable
Refrigerated: Acceptable
Frozen: 1 year
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Methodology
Real-Time RT-PCR
FDA Status
This test was developed, and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.
Setup Schedule
Reference Range
Clinical Significance